1.Risk factors for liver cirrhosis in chronic hepatitis B patients with high metabolic risks and establishment of a predictive model
Yuping ZOU ; Li YAO ; Jun ZOU ; Liwei LI ; Fuqing CAI ; Jiean HUANG
Journal of Clinical Hepatology 2025;41(6):1105-1112
		                        		
		                        			
		                        			ObjectiveTo investigate the main risk factors for liver cirrhosis in chronic hepatitis B (CHB) patients with high metabolic risk, to establish a noninvasive predictive model, and to compare the diagnostic efficiency of this model and other models including fibrosis-4 (FIB-4), aspartate aminotransferase-to-platelet ratio index (APRI), gamma-glutamyl transpeptidase-to-platelet ratio (GPR), and Forns index. MethodsA total of 527 CHB patients with high metabolic risks who were admitted to The Second Affiliated Hospital of Guangxi Medical University from September 1, 2017 to October 31, 2022 were enrolled as subjects, and they were randomly divided into modeling group with 368 patients and validation group with 159 patients at a ratio of 7∶3. The LASSO regression analysis and the multivariate Logistic regression analysis were performed for the modeling group to identify independent risk factors, and a nomogram model was established. The receiver operating characteristic (ROC) curve, the calibration curve, and the decision curve analysis were used to validate the nomogram prediction model in the modeling group and the validation group and assess its discriminatory ability, calibration, and clinical practicability. The Delong test was used to compare the area under the ROC curve (AUC) of the nomogram prediction model and other models. ResultsThe multivariate Logistic regression analysis showed that prealbumin (odds ratio [OR] = 0.993, 95% confidence interval [CI]: 0.988 — 0.999, P= 0.019), thrombin time (OR=1.182, 95% CI: 1.006 — 1.385, P=0.047), log10 total bilirubin (TBil) (OR=1.710, 95%CI: 1.239 — 2.419, P=0.001), and log10 alpha-fetoprotein (AFP) (OR=1.327, 95%CI: 1.052 — 1.683, P=0.018) were independent influencing factors for liver cirrhosis in CHB patients with high metabolic risks. A nomogram model for risk prediction was established based on the multivariate analysis, which had an AUC of 0.837 (95%CI: 0.788 — 0.888), a specificity of 73.5%, and a sensitivity of 84.7%, as well as a significantly higher diagnostic efficiency than the models of FIB-4 (0.739), APRI (0.802), GPR (0.800), and Forns index (0.709) (Z=2.815, 2.271, 1.989, and 2.722, P=0.005, 0.017, 0.045, and 0.006). ConclusionThe nomogram model established based on prealbumin, thrombin time, log10 TBil, and log10 AFP has a certain clinical application value. 
		                        		
		                        		
		                        		
		                        	
2.Prevention and treatment of lipoic acid-niacin on blue-light-induced retinal damage in rats
Tianhao CHENG ; Yuping ZOU ; Liulian JIAN ; Mengyi ZHANG ; Yixuan DOU
International Eye Science 2024;24(2):196-202
		                        		
		                        			
		                        			 AIM: To investigate the preventive effect and optimal drug dose of lipoic acid-niacin(N2L)against blue light-induced retinal damage in SD rats, and to explore its possible protective mechanism.METHODS: A total of 36 specific pathogen free-grade male SD rats of 150-200 g were selected and randomly divided into normal control group, blue light injury group, N2L low-dose group(1.0 mg/kg), N2L medium-dose group(2.5 mg/kg), N2L high-dose group(5.0 mg/kg), and physiological saline group, with 6 rats in each group. The normal control group was reared in a 12 h dark and light cycle, and the rest of the groups received 9 h of daily light exposure, 3 h of blue light irradiation with a wavelength of 455 nm and an intensity of 3000±50 lx, and 12 h of darkness to establish the injury model, and were exposed to light exposure for 14 d. For 14 consecutive durations, a 1 mL dose of the corresponding drug was injected intraperitoneally. The rats were reared for another 5 d with a regular 12 h light-dark cycle and were examined by electroretinography. Specimens were prepared by over anesthesia, HE staining, and the thickness of the outer nuclear layer was observed under a optical microscope; superoxide dismutases(SOD)activity was detected by CheKineTM SOD Activity Assay Kit; and the retinal Caspase-3, quinone oxidoreductase 1(NQO1), glutathione S transferase(GST), Bcl-2, and Bax protein expression in rat retina were detected by Western blot.RESULTS: The amplitude of b-wave in dark-vision ERG 3.0 and 10.0(cd·s)/m2 stimulated light, b-wave in bright-vision ERG 3.0(cd·s)/m2 stimulated light, and the amplitude of the 2nd wave peak of oscillatory potential were significantly lower in blue light injury group than that in the normal control group(all P<0.01), while the amplitude was significantly higher in the N2L medium-dose group than in the blue light injury group(all P<0.05), and was not statistically different from that of the normal control group; the thickness of the retina in the blue light injury group was decreased in the ONL compared with that of the normal control group(P<0.001), while in the N2L medium dose group, it was thicker than that of the blue light injury group(P<0.001), and there was no statistically significant difference from the normal control group; SOD activity was significantly higher in the N2L medium-dose group than in the remaining 5 groups(P<0.05); the expression of Caspase-3, Bax, and NQO1 in the blue light injury group was higher than that of the normal control group(all P<0.01), and expression of Bax and Caspase-3 was significantly lower in the N2L medium-dose group compared with the blue light injury group(all P<0.001), whereas GST, NQO1 and Bcl-2 were significantly increased(all P<0.01).CONCLUSION:A concentration of 2.5 mg/kg N2L can effectively antagonize the damaging effect of blue light on the retina of SD rats, and it is expected to be a preventive and curative drug for it. 
		                        		
		                        		
		                        		
		                        	
3.Genetic analysis of a case of mild epilepsy due to variant of SCN9A gene.
Xunqiang YIN ; Yuping NIU ; Yang ZOU ; Yuan GAO
Chinese Journal of Medical Genetics 2023;40(3):344-348
		                        		
		                        			OBJECTIVE:
		                        			To explore the genetic etiology of a patient with epilepsy and provide genetic counseling.
		                        		
		                        			METHODS:
		                        			A patient who had visited the Center for Reproductive Medicine of Shandong University on November 11, 2020 was selected as the study subject, and her clinic information was collected. Candidate variant was identified through whole exome sequencing (WES), and Sanger sequencing was used for validation. Possible transcriptional changes caused by the variant was detected by reverse transcription-PCR and Sanger sequencing.
		                        		
		                        			RESULTS:
		                        			The patient was a 35-year-old female with no fever at the onset, loss of consciousness and abnormal firing in the temporal lobe, manifesting predominantly as convulsions and fainting. WES revealed that she had harbored a heterozygous c.2841+5G>A variant of the SCN9A gene, which was verified by Sanger sequencing. cDNA sequencing confirmed that 154 bases were inserted between exons 16 and 17 of the SCN9A gene, which probably produced a truncated protein and affected the normal function of the SCN9A protein. Based on the guidelines from the American College of Medical Genetics and Genomics, the c.2841+5G>A variant was classified as likely pathogenic (PVS1_Strong+PM2_Supporting).
		                        		
		                        			CONCLUSION
		                        			The c.2841+5G>A variant of the SCN9A gene probably underlay the epilepsy in this patient. Above finding has enriched the variant spectrum of the SCN9A gene and provided a basis for the prenatal diagnosis and preimplantation genetic testing for this patient.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Epilepsy/genetics*
		                        			;
		                        		
		                        			Seizures
		                        			;
		                        		
		                        			Exons
		                        			;
		                        		
		                        			DNA, Complementary
		                        			;
		                        		
		                        			Genetic Counseling
		                        			;
		                        		
		                        			NAV1.7 Voltage-Gated Sodium Channel
		                        			
		                        		
		                        	
4.Correlation of Tfh cell content in peripheral blood proportion and intracellular IL-21 with retinal damage caused by blue light
Mengyi ZHANG ; Yangyang YU ; Zhengya LI ; Yongzhen YU ; Chunli ZHANG ; Tianhao CHENG ; Yixiao LEI ; Wenjie ZHOU ; Xiulan ZOU ; Yuping ZOU
The Journal of Practical Medicine 2023;39(21):2743-2749
		                        		
		                        			
		                        			Objective To investigate the correlation between the proportion of peripheral blood follicular T helper cells(Tfh cells)and intracellular interleukin-21(IL-21)content with blue light retinal injury.Methods Brown Norway(BN)rats were randomly divided into 4 groups and were exposed to blue light for 3 hours a day to establish retinal light damage model.According to the duration of illumination,the rats was divided into 0 days(control group),3 days(3 d group),7 days(7 d group)and 14 days(14 d group).The proportion of Tfh cells and content of IL-21 in Tfh cells in peripheral blood of each group was detected by flow cytometry and ELISA sepa-rately after illumination.Electroretinogram(ERG)was used to evaluate retinal function.The changes of fundus in rats were observed by fundus photography.The thickness of outer nuclear layer of retina was analyzed by HE staining.Results After retinal blue light injury,with the extension of illumination time,the proportion of Tfh cells in peripheral blood and intracellular IL-21 content both increased(P<0.05).ERG showed that retinal function decreased after light damage and aggravated with the extension of illumination time,the latency and ampli-tudes of A-wave and B-wave increased and decreased respectively(P<0.05).The retinal fundus of rats showed depigmentation in 3 d,and the retinal vessels became thinner and exudate with the extension of illumination time.HE staining showed that the outer nuclear layer of retina(ONL)became thinner(P<0.05).Correlation analy-sis indicated that the proportion of Tfh cells in peripheral blood and the intracellular IL-21 content could jointly reflect the degree of injury(P<0.000 1),and the proportion of Tfh cells in peripheral blood was negatively corre-lated with ONL thickness and the amplitude of a and b waves,positively correlated with the peak time of a and b waves,(P<0.0001).Conclusion The proportion of Tfh cells in peripheral blood and the intracellular IL-21 content were increased after blue light damage to retina,and were significantly increased with the extension of light time with a certain correlation.
		                        		
		                        		
		                        		
		                        	
5.Clinical treatment guideline for pulmonary blast injury (version 2023)
Zhiming SONG ; Junhua GUO ; Jianming CHEN ; Jing ZHONG ; Yan DOU ; Jiarong MENG ; Guomin ZHANG ; Guodong LIU ; Huaping LIANG ; Hezhong CHEN ; Shuogui XU ; Yufeng ZHANG ; Zhinong WANG ; Daixing ZHONG ; Tao JIANG ; Zhiqiang XUE ; Feihu ZHOU ; Zhixin LIANG ; Yang LIU ; Xu WU ; Kaican CAI ; Yi SHEN ; Yong SONG ; Xiaoli YUAN ; Enwu XU ; Yifeng ZHENG ; Shumin WANG ; Erping XI ; Shengsheng YANG ; Wenke CAI ; Yu CHEN ; Qingxin LI ; Zhiqiang ZOU ; Chang SU ; Hongwei SHANG ; Jiangxing XU ; Yongjing LIU ; Qianjin WANG ; Xiaodong WEI ; Guoan XU ; Gaofeng LIU ; Junhui LUO ; Qinghua LI ; Bin SONG ; Ming GUO ; Chen HUANG ; Xunyu XU ; Yuanrong TU ; Liling ZHENG ; Mingke DUAN ; Renping WAN ; Tengbo YU ; Hai YU ; Yanmei ZHAO ; Yuping WEI ; Jin ZHANG ; Hua GUO ; Jianxin JIANG ; Lianyang ZHANG ; Yunfeng YI
Chinese Journal of Trauma 2023;39(12):1057-1069
		                        		
		                        			
		                        			Pulmonary blast injury has become the main type of trauma in modern warfare, characterized by externally mild injuries but internally severe injuries, rapid disease progression, and a high rate of early death. The injury is complicated in clinical practice, often with multiple and compound injuries. Currently, there is a lack of effective protective materials, accurate injury detection instrument and portable monitoring and transportation equipment, standardized clinical treatment guidelines in various medical centers, and evidence-based guidelines at home and abroad, resulting in a high mortality in clinlcal practice. Therefore, the Trauma Branch of Chinese Medical Association and the Editorial Committee of Chinese Journal of Trauma organized military and civilian experts in related fields such as thoracic surgery and traumatic surgery to jointly develop the Clinical treatment guideline for pulmonary blast injury ( version 2023) by combining evidence for effectiveness and clinical first-line treatment experience. This guideline provided 16 recommended opinions surrounding definition, characteristics, pre-hospital diagnosis and treatment, and in-hospital treatment of pulmonary blast injury, hoping to provide a basis for the clinical treatment in hospitals at different levels.
		                        		
		                        		
		                        		
		                        	
6.Correlation of serum albumin level at admission with clinical prognoses in patients with acute traumatic brain injury
Dongbo ZOU ; Yuting YANG ; Yuping PENG ; Yongxiang YANG ; Jianing LUO ; Tao YANG ; Jingmin CHENG ; Yuan MA
Chinese Journal of Neuromedicine 2023;22(9):904-909
		                        		
		                        			
		                        			Objective:To explore the correlation of serum albumin level at admission with clinical prognoses in patients with acute traumatic brain injury (TBI).Methods:One hundred and fifty-four patients with acute moderate-extreme severe TBI (Glasgow Coma Scale [GCS] scores of 3-12 at admission) in Department of Neurosurgery, General Hospital of Western Theater Command from January 1, 2019 to December 31, 2020 were chosen. The comprehensive clinical data of these patients were collected, including age, gender, GCS scores, serum albumin level (hypoalbuminemia defined as<35 g/L), hemoglobin level, comorbidities, treatment measures, and prognoses 6 months after discharge (poor prognosis defined as Glasgow outcome Scale [GOS] scores of 1-2, and good prognosis defined as GOS scores of 3-5). Univariate and multivariate Logistic regressions were used to identify the independent factors for clinical prognoses of these patients, and differences in poor prognosis rate, length of ICU stay, and total hospital cost were compared between different groups.Results:Among the 154 patients, 43 had poor prognosis and 111 had good prognosis. Serum albumin level at admission ( OR=0.916, 95% CI: 0.843-0.996, P=0.001) and GCS scores at admission ( OR=0.701, 95% CI: 0.594-0.828, P<0.001) were independent factors for prognosis. Patients with hypoalbuminemia ( n=70) displayed significantly higher poor prognosis rate, longer ICU stays, and increased total hospitalization cost compared with those without hypoalbuminemia ( n=84, P<0.05); specifically, in patients with GCS scores of 9-12 at admission ( n=58), those with hypoalbuminemia ( n=27) exhibited significantly higher poor prognosis rate, longer ICU stays, and higher total hospitalization cost than their non-hypoalbuminemia counterparts ( n=31, P<0.05); similarly, in patients with GCS scores of 3-8 at admission ( n=96), those with hypoalbuminemia ( n=74) had significantly higher poor prognosis rate than their non-hypoalbuminemia counterparts ( n=22, P<0.05). In patients with good prognosis, those with hypoalbuminemia ( n=56) showed significantly longer total hospital stays, prolonged ICU stays, and increased total hospitalization cost compared with those without hypoalbuminemia ( n=55, P<0.05). Conclusion:Low serum albumin level at admission is likely to lead to poor prognosis, prolonged ICU stays and increased total hospitalization cost in patients with acute TBI.
		                        		
		                        		
		                        		
		                        	
7.Identification of a novel variant of COL4A5 gene in a pedigree affected with Alport syndrome.
Xiaowei LIU ; Ming GAO ; Yang ZOU ; Lijuan WANG ; Ranran KANG ; Peiwen XU ; Yuping NIU ; Sexin HUANG ; Jie LI ; Hongqiang XIE ; Yuan GAO
Chinese Journal of Medical Genetics 2020;37(8):807-810
		                        		
		                        			OBJECTIVE:
		                        			To explore the genetic basis for a pedigree affected with Alport syndrome.
		                        		
		                        			METHODS:
		                        			Next generation sequencing and Sanger sequencing was carried out to detect potential variant of the COL4A5 gene among members from the pedigree and 100 unrelated healthy controls.
		                        		
		                        			RESULTS:
		                        			A novel missense c.3293G>T (p.Gly1098Val) variant was found in the COL4A5 gene among 6 affected members but not the unaffected members of the pedigree or the 100 healthy controls. According to the American College of Medical Genetics and Genomics standards and guidelines, the c.3293G>T variant was classified as pathogenic (PP1-strong+PM1+PM2+PP3+PP4).
		                        		
		                        			CONCLUSION
		                        			By destructing the Gly-X-Y structure of its protein product, the c.3293G>T variant of the COL4A5 gene probably underlies the Alport syndrome in this pedigree. Above finding has enriched the spectrum of COL4A5 variants.
		                        		
		                        		
		                        		
		                        	
8.Identification of a novel splicing variant of IDS gene in a pedigree affected with type II glycosaminoglycan product storage disease.
Hongqiang XIE ; Lijuan WANG ; Sexin HUANG ; Jie LI ; Yang ZOU ; Peiwen XU ; Ming GAO ; Ranran KANG ; Yuping NIU ; Xiaowei LIU ; Yuan GAO
Chinese Journal of Medical Genetics 2020;37(7):713-716
		                        		
		                        			OBJECTIVE:
		                        			To analyze variant of IDS gene in a pedigree affected with mucopolysaccharidosis type II (MPS II).
		                        		
		                        			METHODS:
		                        			The proband was subjected to next generation sequencing and Sanger sequencing to identify potential variants. Suspected variant was analyzed by its co-segregation with the disease in the pedigree. Its impact on mRNA splicing was analyzed by using reverse transcription PCR (RT-PCR).
		                        		
		                        			RESULTS:
		                        			A hemizygous IVS1-3T>G variant was found in the IDS gene in the proband. RT-PCR results revealed two abnormal cDNA fragments of 600 bp and 300 bp. The 600 bp fragment had inserted 216 nucleotides at the 3' end of intron 1, while the 300 bp fragment had lost 109 nucleotides at the 5' end of exon 2, which resulted in two truncated proteins comprising 38 and 92 amino acids, respectively, instead of the normal product (550 amino acids). The proband and his mother were respectively hemizygous and heterozygous for the variant. The same variant was not found among 100 normal controls.
		                        		
		                        			CONCLUSION
		                        			The IVS1-3T>G variant of the IDS gene probably underlies the MPS II in this pedigree by causing reduction or elimination of the IDS protein.
		                        		
		                        		
		                        		
		                        	
9.Novel mutations of XPC gene detected in a family affected with xeroderma pigmentosum group C.
Lijuan WANG ; Sexin HUANG ; Jie LI ; Yang ZOU ; Peiwen XU ; Ming GAO ; Ranran KANG ; Hongqiang XIE ; Xianda WEI ; Yuping NIU ; Xiaowei LIU ; Yuan GAO
Chinese Journal of Medical Genetics 2018;35(4):540-543
OBJECTIVETo detect mutations of the XPC (XPC complex subunit, DNA damage recognition and repair factor) gene in a family affected with xeroderma pigmentosum group C (XP-C).
METHODSThe patient was subjected to next-generation sequencing and Sanger sequencing. Suspected mutations were validated by Sanger sequencing. Effect of splicing mutation was confirmed by reverse transcription-PCR (RT-PCR).
RESULTSCompound heterozygous mutations of c.2098G to T and c.2034-7_2040del were found in the XPC gene in the proband. Among these, c.2098G to T (p.G700X) is a nonsense mutation resulting in a truncated XPC protein. C.2034-7_2040del involves the -1 position, which may alter the splice donor site of the intron 11 of XPC and result in a truncated XPC protein with loss of amino acids from 940 to 679 positions. The two mutations were not detected among 100 unrelated healthy controls.
CONCLUSIONMutations of c.2098 G to T and c.2034-7_2040del of the XPC gene may lead to abnormal XPC expression and reduction or elimination of normal XPC functions, which may underlie the disease in this family.
10.A control study of gonadal hormone level in female patients with panic disorder
Zhili ZOU ; Ping SHUAI ; Yulan HUANG ; Jinyu WANG ; Ying HE ; Wenjiao MIN ; Yuping LIU ; Bo ZHOU
Chongqing Medicine 2018;47(15):2038-2041
		                        		
		                        			
		                        			Objective To understand the serum gonadal hormone level of female patients with panic disorder(PD),and to analyze its relationship with the disease severity.Methods The chemiluminescence method was adopted to detect serum gonadal hormone level in 57 female patients with panic disorder and 74 healthy subjects,the panic disorder severity scale (PDSS),Hamilton anxiety scale (HAMA) and Hamilton depression scale (HAMD) were simultaneously used to conduct the investigation.Results The serum pituitary prolactin (PRL) level in the female patients with PD had lower level was higher than that in the control group,the difference was statistically significant (P<0.05);the luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels were lower than those in the control group(P<0.05).The difference of the serum testosterone,estradiol and progesterone levels between the female patients with panic disorder and control group was not statistically significant (P>0.05).The correlation analysis found that serum T level in the female patients with PD was negatively correlated with the disease severity of panic disorder,HAMD total score,retardation factor and sleep disorder factor (P<0.05).Serum LH and FSH were positively correlated with the anxiety somatic factor of HAMA (P<0.05).Serum FSH level was positively correlated with anxiety somatization and the sleep disorder factor of HAMD (P<0.05).Conclusion The disorder of gonadal hormone levels may exist in the female patients with PD,and the serum T level is correlated with the PD severity and depressive symptoms.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail